AirSculpt Files 2025 Annual Report Amendment
Ticker: AIRS · Form: 10-K/A · Filed: Apr 6, 2026 · CIK: 0001870940
Sentiment: neutral
Topics: amendment, annual-report, filing
TL;DR
AIRSCULPT FILED ITS AMENDED 2025 ANNUAL REPORT. CHECK FOR UPDATES.
AI Summary
AirSculpt Technologies, Inc. filed an amendment (10-K/A) to its annual report on April 6, 2026, for the fiscal year ending December 31, 2025. The filing includes various exhibits such as consent of independent registered public accounting firm and certifications from principal executive and financial officers. The company's mailing and business address is 1111 Lincoln Road, Suite 802, Miami Beach, FL 33139.
Why It Matters
This amendment to the annual report provides updated or corrected information for the fiscal year 2025, which is crucial for investors to have the most accurate financial and operational data.
Risk Assessment
Risk Level: low — This filing is an amendment to a previous annual report and does not appear to introduce new material risks.
Key Numbers
- 0001870940 — CIK Number (Unique identifier for AirSculpt Technologies, Inc.)
- 2025-12-31 — Fiscal Year End (The period covered by the annual report.)
Key Players & Entities
- AirSculpt Technologies, Inc. (company) — Filer
- 0001870940 (company) — CIK Number
- 2025-12-31 (date) — Period of Report
- 2026-04-06 (date) — Filing Date
- 1111 LINCOLN ROAD SUITE 802 MIAMI BEACH FL 33139 (address) — Mailing and Business Address
FAQ
What specific information was amended in the 10-K filing?
The filing is a 10-K/A, indicating an amendment to the annual report. Specific details of the amendments are not provided in the summary information but would be within the full document.
When was this amended annual report filed?
The amended annual report (10-K/A) was filed on April 6, 2026.
What is the CIK number for AirSculpt Technologies, Inc.?
The CIK number for AirSculpt Technologies, Inc. is 0001870940.
What is the company's primary business address?
The company's business address is 1111 Lincoln Road, Suite 802, Miami Beach, FL 33139.
What period does this 10-K/A filing cover?
This 10-K/A filing is an amendment for the period of report ending December 31, 2025.
Filing Stats: 4,448 words · 18 min read · ~15 pages · Grade level 14.2 · Accepted 2026-04-06 06:32:22
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share AIRS The Nasdaq Global Market
- $2.6 m — sted Net (Loss)/Income of approximately $2.6 million, and an overstatement of Adjusted
- $2.7 m — verstated Adjusted Net (Loss)/Income by $2.7 million, resulting in a $0.1 million net
- $0.1 million — /Income by $2.7 million, resulting in a $0.1 million net overstatement for the year ended De
- $151.8 million — r ended December 31, 2025, we generated $151.8 million of revenue compared to $180.4 million f
- $180.4 million — d $151.8 million of revenue compared to $180.4 million for the year ended December 31, 2024, w
- $11 billion — htening procedures, was estimated to be $11 billion in 2022 and expected to grow at a 9% co
- $12,809 — 2025, we generated revenue per case of $12,809 on average. We require 100% private pay
- $152 million — er 31, 2025, we generated approximately $152 million of revenue compared to approximately $1
- $180 million — on of revenue compared to approximately $180 million for the year ended December 31, 2024, w
Filing Documents
- airs-20251231.htm (10-K/A) — 1806KB
- ex231-consentofindependent.htm (EX-23.1) — 2KB
- a10-kexhibit31112312025.htm (EX-31.1) — 11KB
- a10-kexhibit31212312025.htm (EX-31.2) — 11KB
- a10-kexhibit32112312025.htm (EX-32.1) — 8KB
- airs-20251231_g1.jpg (GRAPHIC) — 5KB
- airs-20251231_g2.jpg (GRAPHIC) — 6KB
- airs-20251231_g3.jpg (GRAPHIC) — 6KB
- airs-20251231_g4.jpg (GRAPHIC) — 11KB
- 0001870940-26-000021.txt ( ) — 8892KB
- airs-20251231.xsd (EX-101.SCH) — 57KB
- airs-20251231_cal.xml (EX-101.CAL) — 108KB
- airs-20251231_def.xml (EX-101.DEF) — 276KB
- airs-20251231_lab.xml (EX-101.LAB) — 724KB
- airs-20251231_pre.xml (EX-101.PRE) — 542KB
- airs-20251231_htm.xml (XML) — 1061KB
Risk Factors
Item 1A. Risk Factors 46
Unresolved Staff Comments
Item 1B. Unresolved Staff Comments 46
Cybersecurity
Item 1C. Cybersecurity 46
Properties
Item 2. Properties 47
Legal Proceedings
Item 3. Legal Proceedings 48
Mine Safety Disclosures
Item 4. Mine Safety Disclosures 48 Part II 49
Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 49
Reserved
Item 6. Reserved 49
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations 49
Quantitative and Qualitative Disclosures about Market Risk
Item 7A. Quantitative and Qualitative Disclosures about Market Risk 64
Financial Statements and Supplementary Data
Item 8. Financial Statements and Supplementary Data 64
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 90
Controls and Procedures
Item 9A. Controls and Procedures 90
Other Information
Item 9B. Other Information 92
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 92 Part III 93
Directors, Executive Officers and Corporate Governance
Item 10. Directors, Executive Officers and Corporate Governance 93
Executive Compensation
Item 11. Executive Compensation 93
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 93
Certain Relationships and Related Transactions, and Director Independence
Item 13. Certain Relationships and Related Transactions, and Director Independence 93
Principal Accountant Fees and Services
Item 14. Principal Accountant Fees and Services 93 Part IV 94
Exhibits and Financial Statement Schedules
Item 15. Exhibits and Financial Statement Schedules 94
Form 10-K Summary
Item 16. Form 10-K Summary 96
Signatures
Signatures 97 Table of Contents CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS We have made statements in the sections titled "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Quantitative and Qualitative Disclosures About Market Risk" and in other sections of this Annual Report on Form 10-K that are forward-looking statements. In some cases, you can identify these statements by forward-looking words such as "may," "might," "will," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential" or "continue," the negative of these terms and other comparable terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. You are cautioned that there are important risks and uncertainties, many of which are beyond our control, that could cause our actual results, level of activity, performance or achievements to differ materially from the projected results, level of activity, performance or achievements that are expressed or implied by such forward-looking statements. We qualify all of our forward-looking statements by these cautionary statements. Our future results could be affected by a variety of other factors, including, but not limited to, inability to sell equity or other securities in the future at a time when we might otherwise wish to effect sales; inability to raise capital on commercially reasonable terms, if at all; the risk that any future financings may dilute our stockholders or restrict our business; failure to stabilize same-center performance; not being able to optimize our market
Business
Item 1. Business Unless otherwise indicated or the context otherwise requires, references in this Annual Report on Form 10-K to the "Company," "AirSculpt," "we," "us" and "our" refer to AirSculpt Technologies, Inc. and its consolidated subsidiaries and the Professional Associations (as defined hereinafter). Our Company AirSculpt is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. We believe our treatment results and elite patient experience have positioned AirSculpt as a preferred body contouring brand. We performed 11,852 body contouring procedures in 2025. Our proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches and no general anesthesia to achieve transformational change that appears both natural and smooth. Our patients are guided by surgeons, nurses and patient care consultants through every step of the experience. We have a broad offering of fat removal procedures across treatment areas. We also offer innovative fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Our innovative body contouring procedures include the Power BBL , a Brazilian butt lift procedure, the Up a Cup , a breast enhancement procedure, and the Hip Flip , an hourglass contouring procedure. Our motivation to provide the best body contouring outcomes for our patients fuels our innovation. Further, the Company introduced AirSculpt + and AirSculpt Smooth in fiscal year 2022. AirSculpt + permanently removes fat and tightens the skin with unparalleled precision and finesse. Patients first target any area containing excess f